Logo Logo

Publications by Aktas, Bahriye

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 7.

Journal article

Gluz, Oleg; Nitz, Ulrike; Liedtke, Cornelia; Christgen, Matthias; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Bangemann, Nikola; Lindner, Christoph; Kuemmel, Sherko; Clemens, Michael; Potenberg, Jochem; Staib, Peter; Kohls, Andreas; Schumann, Raquel von; Harbeck, Nadia (2018): Comparison of Neoadjuvant Nab-Paclitaxe plus Carboplatin vs Nab-Paclitaxe plus Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results. In: Jnci-Journal of the National Cancer Institute, Vol. 110, No. 6, djx258: pp. 628-637

Harbeck, Nadia; Gluz, Oleg; Christgen, Matthias; Kates, Ronald Ernest; Braun, Michäl; Küemmel, Sherko; Schumacher, Claudia; Potenberg, Jochem; Krämer, Stefan; Kleine-Tebbe, Anke; Augustin, Doris; Aktas, Bahriye; Forstbauer, Helmut; Tio, Joke; Schumann, Raquel von; Liedtke, Cornelia; Grischke, Eva-Maria; Schumacher, Johannes; Würstlein, Rachel; Kreipe, Hans Heinrich; Nitz, Ulrike Anneliese (2017): De-Escalation Strategies in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer (BC): Final Analysis of the West German Study Group Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early BC HER2-and Hormone Receptor-Positive Phase II Randomized Trial-Efficacy, Safety, and Predictive Markers for 12 Weeks of Neoadjuvant Trastuzumab Emtansine With or Without Endocrine Therapy (ET) Versus Trastuzumab Plus ET. In: Journal of Clinical Oncology, Vol. 35, No. 26: pp. 3046-3056

Nitz, Ulrike; Gluz, Oleg; Christgen, Matthias; Kates, Ronald E.; Clemens, Michael; Malter, Wolfram; Nuding, Benno; Aktas, Bahriye; Kümmel, Sherko; Reimer, Toralf; Stefek, Andrea; Lorenz-Salehi, Fatemeh; Krabisch, Petra; Just, Marianne; Augustin, Doris; Liedtke, Cornelia; Chao, Calvin; Shak, Steven; Würstlein, Rachel; Kreipe, Hans H.; Harbeck, Nadia (2017): Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial. In: Breast Cancer Research and Treatment, Vol. 165, No. 3: pp. 573-583

Banys-Paluchowski, Malgorzata; Witzel, Isabell; Riethdorf, Sabine; Rack, Brigitte; Janni, Wolfgang; Fasching, Peter Andreas; Solomayer, Erich-Franz; Aktas, Bahriye; Kasimir-Bauer, Sabine; Pantel, Klaus; Fehm, Tanja; Müller, Volkmar (2017): Clinical Relevance of Serum HER2 and Circulating Tumor Cell Detection in Metastatic Breast Cancer Patients. In: Anticancer Research, Vol. 37, No. 6: pp. 3117-3128

Gluz, Oleg; Nitz, Ulrike A.; Christgen, Matthias; Kates, Ronald E.; Shak, Steven; Clemens, Michael; Kraemer, Stefan; Aktas, Bahriye; Kuemmel, Sherko; Reimer, Toralf; Kusche, Manfred; Heyl, Volker; Lorenz-Salehi, Fatemeh; Just, Marianne; Hofmann, Daniel; Degenhardt, Tom; Liedtke, Cornelia; Svedman, Christer; Wuerstlein, Rachel; Kreipe, Hans H.; Harbeck, Nadia (2016): West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment. In: Journal of Clinical Oncology, Vol. 34, No. 20: 2341-U66

Mueller, Volkmar; Riethdorf, Sabine; Rack, Brigitte; Janni, Wolfgang; Fasching, Peter A.; Solomayer, Erich; Aktas, Bahriye; Kasimir-Bauer, Sabine; Pantel, Klaus; Fehm, Tanja (2012): Prognostic impact of circulating tumor cells assessed with the CellSearch System (TM) and AdnaTest Breast (TM) in metastatic breast cancer patients: the DETECT study. In: Breast Cancer Research 14:R118 [PDF, 378kB]

Mueller, Volkmar; Riethdorf, Sabine; Rack, Brigitte; Janni, Wolfgang; Fasching, Peter A.; Solomayer, Erich; Aktas, Bahriye; Kasimir-Bauer, Sabine; Zeitz, Julia; Pantel, Klaus; Fehm, Tanja (2011): Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer. In: Breast Cancer Research 13:R71 [PDF, 432kB]

This list was generated on Fri Dec 13 06:23:37 2019 CET.